Brain type carnosinase in dementia: a pilot study.

The MD group, but not the AD group, demonstrated a significant trend with carnosinase activity decreasing with duration of disease (from first recorded date of diagnosis to date of blood collection) (r = -0.76, p = 0.049).

also in 6,248 other papers